ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc.
NEW YORK, May 04, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc....
Source: globenewswire.com
📰 Nasdaq Ocgn News
Nasdaq Ocgn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Ocgn. Real-time updates on events, politics, business and more.
ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc.
NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc....
Source: globenewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Ocugen, Inc.
NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ocugen, Inc....
Source: globenewswire.com
Ocugen to Present on Modifier Gene Therapy Platform at
MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
Source: globenewswire.com
Ocugen Announces Dosing Completion of Subjects with
MALVERN, Pa., April 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
United States Syedm Shah Exchange Commission Ocugen Inc Head Of Communications Retina Service At Gundersen Health System
Source: globenewswire.com
Ocugen to Host Conference Call on Tuesday, April 2 at 8:30
MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
Exchange Commission Head Of Communications Ocugen Inc Private Securities Litigation Reform Act Nasdaq Ocgn Gene Therapy
Source: globenewswire.com
Ocugen (NASDAQ:OCGN) Reaches New 1-Year High at $1.98
Ocugen, Inc. (NASDAQ:OCGN – Get Free Report) shares hit a new 52-week high during trading on Monday . The stock traded as high as $1.98 and last traded at $1.97, with a volume of 10300270 shares traded. The stock had previously closed at $1.64. Analysts Set New Price Targets Separately, HC Wainwright reaffirmed a “buy” […]
Ocugen Company Profile Sigma Securities Lazard Asset Management Ocugen Inc Belpointe Asset Management Schonfeld Strategic Advisors
Source: wkrb13.com
Ocugen (NASDAQ:OCGN) Hits New 52-Week High at $1.98
Ocugen, Inc. (NASDAQ:OCGN – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $1.98 and last traded at $1.97, with a volume of 10300270 shares changing hands. The stock had previously closed at $1.64. Wall Street Analysts Forecast Growth Separately, HC Wainwright reaffirmed […]
Ocugen Inc Belpointe Asset Management Schonfeld Strategic Advisors Ocugen Company Profile Lazard Asset Management Sigma Securities
Source: tickerreport.com
Ocugen to Host Clinical Showcase in New York City
Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase 1/2 clinical trial...
Source: globenewswire.com
Ocugen (NASDAQ:OCGN) PT Raised to $7.00
Ocugen (NASDAQ:OCGN – Get Free Report) had its price target upped by equities researchers at HC Wainwright from $5.00 to $7.00 in a research note issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright also issued estimates for Ocugen’s FY2024 earnings at ($0.25) EPS, FY2025 earnings at […]
Lazard Asset Management Sigma Securities Belpointe Asset Management Schonfeld Strategic Advisors Ocugen Inc Get Free Report
Source: wkrb13.com